Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses
PS Sullivan, AS Johnson, ES Pembleton… - The Lancet, 2021 - thelancet.com
The HIV epidemic in the USA began as a bicoastal epidemic focused in large cities but, over
nearly four decades, the epidemiology of HIV has changed. Public health surveillance data …
nearly four decades, the epidemiology of HIV has changed. Public health surveillance data …
The opioid crisis and HIV in the USA: deadly synergies
The opioid epidemic is one of the greatest public health problems that the USA faces. Opioid
overdose death rates have increased steadily for more than a decade and doubled in 2013 …
overdose death rates have increased steadily for more than a decade and doubled in 2013 …
[HTML][HTML] Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis — United States, 2013–2018
NS Harris - MMWR. Morbidity and mortality weekly report, 2019 - cdc.gov
Background: Approximately 38,000 new human immunodeficiency virus (HIV) infections
occur in the United States each year; these infections can be prevented. A proposed …
occur in the United States each year; these infections can be prevented. A proposed …
Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement
KW Davidson, MJ Barry, CM Mangione, M Cabana… - Jama, 2021 - jamanetwork.com
Importance Chlamydia and gonorrhea are among the most common sexually transmitted
infections in the US. Infection rates are highest among adolescents and young adults of both …
infections in the US. Infection rates are highest among adolescents and young adults of both …
[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021
KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …
Is risk compensation threatening public health in the covid-19 pandemic?
E Mantzari, GJ Rubin, TM Marteau - Bmj, 2020 - bmj.com
Is risk compensation threatening public health in the covid-19 pandemic? | The BMJ Skip to
main content Intended for healthcare professionals Access provided by Google Indexer …
main content Intended for healthcare professionals Access provided by Google Indexer …
[HTML][HTML] Toward greater pre-exposure prophylaxis equity: increasing provision and uptake for Black and Hispanic/Latino individuals in the US
RA Bonacci, DK Smith, BO Ojikutu - American journal of preventive …, 2021 - Elsevier
Pre-exposure prophylaxis (PrEP) is highly effective at preventing HIV acquisition and is a
critical tool in the Ending the HIV Epidemic in the US initiative. However, major racial and …
critical tool in the Ending the HIV Epidemic in the US initiative. However, major racial and …
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
RP Matthews, M Patel, SE Barrett, L Haspeslagh… - Nature Medicine, 2021 - nature.com
Abstract Islatravir (MK-8591) is a highly potent type 1 human immunodeficiency virus (HIV-1)
nucleoside reverse transcriptase translocation inhibitor with a long intracellular half-life that …
nucleoside reverse transcriptase translocation inhibitor with a long intracellular half-life that …
Artificial intelligence and machine learning for HIV prevention: emerging approaches to ending the epidemic
Abstract Purpose of Review We review applications of artificial intelligence (AI), including
machine learning (ML), in the field of HIV prevention. Recent Findings ML approaches have …
machine learning (ML), in the field of HIV prevention. Recent Findings ML approaches have …
HIV pre-exposure prophylaxis implementation cascade among health care professionals in the United States: implications from a systematic review and meta-analysis
Although pre-exposure prophylaxis (PrEP) has been approved for primary HIV prevention
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …